FIGURE

Fig. 2

ID

ZDB-FIG-250610-57

Publication

Wan et al., 2025 - Sculponeatin A induces mitochondrial dysfunction in non-small cell lung cancer through WWP2-mediated degradation of mitochondrial STAT3

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

sptA inhibits aerobic glycolysis and mitochondrial respiration in NSCLC cells. (a, b) Cells were treated with sptA for 24 h, after which the ECAR was detected using a Seahorse XF24. Glycolysis, glycolytic capacity and the glycolytic reserve were quantified based on the ECAR (n = 5). (c, d) Cells were treated with sptA for 24 h. Lactate production (c) and glucose uptake (d) were measured (n = 5). (e-g) Cells were treated with sptA for 24 h, after which the OCR was determined using a Seahorse XF24. Basal respiration, ATP production and maximal respiration were quantified based on the OCR (n = 5). Data shown are means ± SD, with individual values in (b-e, g). *P < 0.05, significantly different from control (0 nM sptA).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Br. J. Pharmacol.